An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.

Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.

A researcher in South Africa investigating a rare skin disease was losing hope of a breakthrough. Then she made a discovery.

All treatments that exist today started with patients volunteering to participate in a study and healthcare professionals offering their expertise.

Collaborations are driving advances in sickle cell disease research, bringing new hope to patients.

Three years after discussing how to reuse an old scientific measuring device, Novartis scientists are now testing this idea as part of an innovative research project.

Novartis researchers use automation to rapidly identify starting points for new drugs.

Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.

An antibody that boosts muscle mass could mean independence for the frail and elderly. Learn how Novartis research aims to improve healthy aging.

The cause of a rare, inherited, often fatal kidney disease in many patients remained elusive for years, despite multiple attempts to solve the mystery. Then in 2012, a team of researchers cracked some of the unsolved cases in just six weeks.